Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 9, 2003, Pages 1234-1238

  Pfützner, Andreas ^a,c   Kunt, Thomas ^b   Langenfeld, Matthias ^a   Löbig, Mirjam ^a   Knesovic, Maja ^a   Forst, Thomas ^a  

^a Institute for Clinical Research and Development   (Germany)

^b Al Zayed Hospital   (United Arab Emirates)

^c UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

cell function; Chemiluminescence assay; Intact proinsulin; Total proinsulin; Type 2 diabetes

Indexed keywords

PROINSULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL FUNCTION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

CHEMILUMINESCENT MEASUREMENTS; CLINICAL LABORATORY TECHNIQUES; DIABETES MELLITUS, TYPE 2; IMMUNOASSAY; PROINSULIN;

EID: 0142093116     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.189     Document Type: Article

References (27)

1. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, et al. Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1990; 70:1247-53.
2. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, et al. Insulin deficiency in non-insulin-dependent diabetes. Lancet 1989; 293-5.
3. Hanley AJ, D'Agostino R, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, et al. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes 2002; 51:1263-70.
4. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1998; 31:355-60.
5. Haffner SM, Gonzalez C, Mykkännen L, Stern M. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to type 2 diabetes: the Mexico City Diabetes Study. Diabetologia 1997; 40:830-7.
6. Inoue I, Takahashi K, Katayama S, Harada Y, Negishi K, Ishii J, et al A higher proinsulin response to glucose loading predicts deteriorating fasting plasma glucose and worsening to diabetes in subjects with impaired glucose tolerance. Diabet Med 1996; 13:330-6.
7. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Berstrom RW, Fujimoto WY. Proinsulin as a marker for the development of type 2 diabetes in Japanese-American men. Diabetes 1995; 44:173-9.
8. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heiner RJ. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to type 2 diabetes in subjects with impaired glucose tolerance: the Hoorn study. Diabetologia 1996; 39:113-8.
9. Arrants J. Hyperinsulinemia and cardiovascular risk. Heart Lung 1994; 23:118-22.
10. Tonomo S, Kato N, Utsugi T, Ohno T, Shimizu M, Fukuda M, et al. The role of insulin in coronary atherosclerosis. Diabetes Res Clin Pract 1994; 22:117-22.
11. Kahn SE, Halban PA. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 1997; 46:1725-32.
12. Nagi D, Ali VM, Walji S, Jain SK, Yudkin JS. Hyperinsulinemia in nondiabetic Asian subjects using specific assays for insulin, intact proinsulin, and des-31,32-proinsulin. Diabetes Care 1996; 19:39-42.
13. Røder ME, Porte D, Schwartz RS, Kahn SE. Disproportionately elevated proinsulin levels reflect the degree of impaired B-cell secretory capacity in patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83:604-8.
14. Mykkänen L, Haffner SM, Kuusito J, Pyorala K, Hales CN, Laakso M. Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 1995; 38:1176-82.
15. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 1999; 223:262-70.
16. Festa A, D'Agostino R, Mykkänen L, Tracy RP, Hales CN, Howard BV, et al. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. Diabetes Care 1999; 22:1688-93.
17. Luzio SD, Lucas I, Owens DR. Importance of validation of immunoassays for intact proinsulin. Clin Chem Lab Med 2001; 39:631-3.
18. Passing H, Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry, part II. J Clin Chem Clin Biochem 1984; 22:431-45.
19. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 8:307-10.
20. Bland JM, Altman DG. Comparing methods of measurements: why plotting difference against standard method is misleading. Lancet 1995; 21:1085-7.
21. Wareham NJ, Byrne CD, Hales CN. Role of insulin and proinsulin in diabetic vascular disease. Metabolism 1995; 44(Suppl 4):76-82.
22. Csorba TR. Proinsulin: biosynthesis, conversion, assay methods and clinical studies. Clin Biochem 1991; 24:447-54.
23. Yudkin JS. Circulating proinsulin-like molecules. J Diabetes Complications 1993; 7:113-23.
24. Nordt TK, Bode C, Sobel BE. Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor type I by proinsulin. Diabetologia 2001; 44:1121-4.
25. Yudkin JS, May M, Elwood P, Yarnell JW, Greenwood R, Davy Smith G. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study. Diabetologia 2002; 45:327-36.
26. Zethelius B, Byberg L, Hales CN, Lithell H, Berne C. Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 2002; 7:2153-8.
27. Blickle JF, Sapin R, Andreas E. Contribution of total and intact proinsulins to hyperinsulinism in subjects with obesity, impaired glucose tolerance or type 2 diabetes. Diabet Metab 2000; 26:274-80.